Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,522 | -9,499 | -6,227 | -11,345 | -14,022 |
| Depreciation Amortization | -208 | -772 | -103 | -50 | -44 |
| Other Working Capital | 1,276 | -182 | -189 | -117 | 528 |
| Other Operating Activity | 6,412 | 2,468 | -101 | -4,019 | 6,551 |
| Operating Cash Flow | $-11,041 | $-7,985 | $-6,620 | $-15,530 | $-6,987 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,816 | N/A | 1,850 | 500 | -2,279 |
| PPE Investments | -41 | -50 | N/A | -16 | -5 |
| Other Investing Activity | 196 | 896 | 340 | -1,030 | 1,624 |
| Investing Cash Flow | $-22,661 | $846 | $2,190 | $-546 | $-660 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 926 | N/A | 0 |
| Common Stock Issued | 24,841 | 12,341 | 7,129 | 13,598 | 12,689 |
| Financing Cash Flow | $24,841 | $12,341 | $8,055 | $13,598 | $12,689 |
| Beginning Cash Position | 18,688 | 13,487 | 9,862 | 12,340 | 7,298 |
| End Cash Position | 9,826 | 18,688 | 13,487 | 9,862 | 12,340 |
| Net Cash Flow | $-8,862 | $5,202 | $3,625 | $-2,479 | $5,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,041 | -7,985 | -6,620 | -15,530 | -6,987 |
| Capital Expenditure | -41 | -50 | N/A | -16 | -5 |
| Free Cash Flow | -11,082 | -8,035 | -6,620 | -15,546 | -6,992 |